Literature DB >> 28985333

Nonhuman Primate Models of Neurodegenerative Disorders.

Marina E Emborg1,2.   

Abstract

Alzheimer's (AD), Huntington's (HD), and Parkinson's (PD) disease are age-related neurodegenerative disorders characterized by progressive neuronal cell death. Although each disease has particular pathologies and symptoms, accumulated evidence points to similar mechanisms of neurodegeneration, including inflammation, oxidative stress, and protein aggregation. A significant body of research is ongoing to understand how these pathways affect each other and what ultimately triggers the onset of the disease. Experiments in nonhuman primates (NHPs) account for only 5% of all research in animals. Yet the impact of NHP studies for clinical translation is much greater, especially for neurodegenerative disorders, as NHPs have a complex cognitive and motor functions and highly developed neuroanatomy. New NHP models are emerging to better understand pathology and improve the platform in which to test novel therapies. The goal of this report is to review NHP models of AD, HD, and PD in the context of the current understanding of these diseases and their contribution to the development of novel therapies.
© The Author(s) 2017. Published by Oxford University Press on behalf of the National Academy of Sciences. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer’s disease; Huntington’s disease; Parkinson’s disease; alpha synuclein; beta amyloid; huntingtin; nonhuman primates

Mesh:

Substances:

Year:  2017        PMID: 28985333      PMCID: PMC5886328          DOI: 10.1093/ilar/ilx021

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  171 in total

1.  Contrasting effects on discrimination learning after hippocampal lesions and conjoint hippocampal-caudate lesions in monkeys.

Authors:  E Teng; L Stefanacci; L R Squire; S M Zola
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

2.  Riluzole reduces incidence of abnormal movements but not striatal cell death in a primate model of progressive striatal degeneration.

Authors:  S Palfi; D Riche; E Brouillet; M C Guyot; V Mary; F Wahl; M Peschanski; J M Stutzmann; P Hantraye
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

Review 3.  Nigral and extranigral pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; C Schultz; R A de Vos; E N Jansen
Journal:  J Neural Transm Suppl       Date:  1995

4.  Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Authors:  Gunasingh J Masilamoni; James W Bogenpohl; David Alagille; Kristen Delevich; Gilles Tamagnan; John R Votaw; Thomas Wichmann; Yoland Smith
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

5.  Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.

Authors:  T B Freeman; F Cicchetti; R A Hauser; T W Deacon; X J Li; S M Hersch; G M Nauert; P R Sanberg; J H Kordower; S Saporta; O Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  Germline transmission in transgenic Huntington's disease monkeys.

Authors:  Sean Moran; Tim Chi; Melinda S Prucha; Kwang Sung Ahn; Fawn Connor-Stroud; Sherrie Jean; Kenneth Gould; Anthony W S Chan
Journal:  Theriogenology       Date:  2015-03-25       Impact factor: 2.740

7.  Safety and tolerability of putaminal AADC gene therapy for Parkinson disease.

Authors:  C W Christine; P A Starr; P S Larson; J L Eberling; W J Jagust; R A Hawkins; H F VanBrocklin; J F Wright; K S Bankiewicz; M J Aminoff
Journal:  Neurology       Date:  2009-10-14       Impact factor: 9.910

8.  Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease.

Authors:  R M Villalba; T Wichmann; Y Smith
Journal:  Brain Struct Funct       Date:  2013-03-19       Impact factor: 3.270

9.  Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.

Authors:  Alison L McCormack; Sally K Mak; Maryam Shenasa; William J Langston; Lysia S Forno; Donato A Di Monte
Journal:  J Neuropathol Exp Neurol       Date:  2008-08       Impact factor: 3.685

10.  Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates.

Authors:  Stéphane Palfi; Emmanuel Brouillet; Béchir Jarraya; Jocelyne Bloch; Caroline Jan; Masahiro Shin; Françoise Condé; Xiao-Jiang Li; Patrick Aebischer; Philippe Hantraye; Nicole Déglon
Journal:  Mol Ther       Date:  2007-05-01       Impact factor: 11.454

View more
  14 in total

1.  Biodistribution of Biomimetic Drug Carriers, Mononuclear Cells, and Extracellular Vesicles, in Nonhuman Primates.

Authors:  Matthew J Haney; Hong Yuan; Steven T Shipley; Zhanhong Wu; Yuling Zhao; Kelly Pate; Jonathan E Frank; Nicole Massoud; Paul W Stewart; Joel S Perlmutter; Elena V Batrakova
Journal:  Adv Biol (Weinh)       Date:  2021-12-22

2.  Quantitative magnetic susceptibility assessed by 7T magnetic resonance imaging in Alzheimer's disease caused by streptozotocin administration.

Authors:  Sangwoo Kim; Youngjeon Lee; Chang-Yeop Jeon; Keunil Kim; Youngjae Jeon; Yeung Bae Jin; Sukhoon Oh; Chulhyun Lee
Journal:  Quant Imaging Med Surg       Date:  2020-03

3.  LC-MS/MS measurement of endogenous oxytocin in the posterior pituitary and CSF of macaques: A pilot study.

Authors:  D W Erikson; S W Blue; A V Kaucher; T A Shnitko
Journal:  Peptides       Date:  2021-03-31       Impact factor: 3.750

4.  In-vivo diffusion MRI protocol optimization for the chimpanzee brain and examination of aging effects on the primate optic nerve at 3T.

Authors:  Xiaodong Zhang; Chun-Xia Li; Yumei Yan; Govind Nair; James K Rilling; James G Herndon; Todd M Preuss; Xiaoping Hu; Longchuan Li
Journal:  Magn Reson Imaging       Date:  2020-12-23       Impact factor: 2.546

5.  α-Synuclein Expression Is Preserved in Substantia Nigra GABAergic Fibers of Young and Aged Neurotoxin-Treated Rhesus Monkeys.

Authors:  Scott C Vermilyea; Scott Guthrie; Iliana Hernandez; Viktorya Bondarenko; Marina E Emborg
Journal:  Cell Transplant       Date:  2019-03-11       Impact factor: 4.064

Review 6.  Stem cell therapy for Parkinson's disease using non-human primate models.

Authors:  Zhen-Zhen Chen; Yu-Yu Niu
Journal:  Zool Res       Date:  2019-09-18

7.  Exploring the conservation of Alzheimer-related pathways between H. sapiens and C. elegans: a network alignment approach.

Authors:  Avgi E Apostolakou; Xhuliana K Sula; Katerina C Nastou; Georgia I Nasi; Vassiliki A Iconomidou
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

8.  Motility Profile of Captive-Bred Marmosets Revealed by a Long-Term In-Cage Monitoring System.

Authors:  Masashi Koizumi; Naotake Nogami; Kensuke Owari; Akiyo Kawanobe; Terumi Nakatani; Kazuhiko Seki
Journal:  Front Syst Neurosci       Date:  2021-04-15

9.  Dynamic evolution of Mhc haplotypes in cynomolgus macaques of different geographic origins.

Authors:  Natasja G de Groot; Nanine de Groot; Annemiek J M de Vos-Rouweler; Annet Louwerse; Jesse Bruijnesteijn; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2022-01-27       Impact factor: 3.330

Review 10.  The Rhesus Macaque as a Translational Model for Neurodegeneration and Alzheimer's Disease.

Authors:  Gail A Stonebarger; Heather A Bimonte-Nelson; Henryk F Urbanski
Journal:  Front Aging Neurosci       Date:  2021-09-03       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.